Sustained response to targeted therapies in a patient with pulmonary hypertension owing to Langerhans cell histiocytosis
Guardado en:
Autores principales: | Aykun Hakgör, Hacer Ceren Tokgöz, Özgür Yaşar Akbal, Seda Tanyeri, Berhan Keskin, Barkın Kültürsay, Ali Karagöz, Cihangir Kaymaz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1cfcd769646041deb18c476255b0f264 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Giant pulmonary artery aneurysm caused by sibutramine-associated pulmonary arterial hypertension: First case in the literature
por: Barkın Kültürsay, et al.
Publicado: (2021) -
Impaired endothelium-dependent and endothelium-independent systemic vasodilatory reserve in pulmonary hypertension regardless the clinical group: A generalized dysfunction beyond the pulmonary arteries?
por: Muhittin Demirel, et al.
Publicado: (2021) -
Unicuspid aortic valve with false aortic dissection appearance: A case report
por: Barkın Kültürsay, et al.
Publicado: (2021) -
Dermoscopy of Congenital Langerhans Cell Histiocytosis
por: Ramon Pigem, et al.
Publicado: (2020) -
Langerhans cell histiocytosis—a case report
por: Thiago Jeunon, et al.
Publicado: (2012)